Immunotherapy in genitourinary malignancies

Immunotherapy in genitourinary malignancies

Abstract Treatment of cancer patients involves a multidisciplinary approach including surgery, radiotherapy, and chemotherapy. Traditionally, patients with metastatic disease are treated with combination chemotherapies or targeted agents. These cytotoxic agents have good response rates and achieve p...

Full description

Bibliographic Details
Main Authors: Kathan Mehta, Keyur Patel, Rahul A. Parikh
Format: Article
Language:English
Published: BMC 2017-04-01
Series:Journal of Hematology & Oncology
Subjects:
Immunotherapy
Genitourinary malignancy
Checkpoint inhibitor
PD-1
PD-L1
CTLA-4
Online Access:http://link.springer.com/article/10.1186/s13045-017-0457-4

Internet

http://link.springer.com/article/10.1186/s13045-017-0457-4

Similar Items